- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Mdm2 and Mdmx in DNA repair
Authors
Keywords
-
Journal
Journal of Molecular Cell Biology
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2016-12-03
DOI
10.1093/jmcb/mjw052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA double-strand-break repair in higher eukaryotes and its role in genomic instability and cancer: Cell cycle and proliferation-dependent regulation
- (2016) Emil Mladenov et al. SEMINARS IN CANCER BIOLOGY
- Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells
- (2015) A. M. Carrillo et al. MOLECULAR CANCER RESEARCH
- Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
- (2015) E. Tonsing-Carter et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- The MRE11 complex: An important source of stress relief
- (2014) Katrin Rein et al. EXPERIMENTAL CELL RESEARCH
- The Mdm Network and Its Regulation of p53 Activities: A Rheostat of Cancer Risk
- (2014) Christine M. Eischen et al. HUMAN MUTATION
- Mdmx promotes genomic instability independent of p53 and Mdm2
- (2014) A M Carrillo et al. ONCOGENE
- Another fork in the road—life or death decisions by the tumour suppressor p53
- (2013) Luis A Carvajal et al. EMBO REPORTS
- The ATM protein kinase: regulating the cellular response to genotoxic stress and more
- (2013) Yosef Shiloh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The ATM signaling network in development and disease
- (2013) Travis H. Stracker et al. Frontiers in Genetics
- MDM2 Inhibitor Nutlin-3a Induces Apoptosis and Senescence in Cutaneous T-Cell Lymphoma: Role of p53
- (2012) Valentina Manfé et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Decreased Mdm2 Expression Inhibits Tumor Development and Extends Survival Independent of Arf and Dependent on p53
- (2012) Christine M. Eischen et al. PLoS One
- HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma
- (2011) R. J. Jones et al. BLOOD
- A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
- (2011) Jane M Valentine et al. BMC CANCER
- Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis
- (2011) Satoshi Watanabe et al. BMC CANCER
- MdmX regulates transformation and chromosomal stability in p53-deficient cells
- (2011) Zdenka Matijasevic et al. CELL CYCLE
- Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression
- (2011) T Lushnikova et al. ONCOGENE
- Abnormal MDMX degradation in tumor cells due to ARF deficiency
- (2011) X Li et al. ONCOGENE
- Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4
- (2010) S. Xiong et al. CANCER RESEARCH
- DNA damage response to the Mdm2 inhibitor Nutlin-3
- (2009) Rajeev Verma et al. BIOCHEMICAL PHARMACOLOGY
- Mdm2 Promotes Genetic Instability and Transformation Independent of p53
- (2008) A. Bouska et al. MOLECULAR AND CELLULAR BIOLOGY
- Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53
- (2008) S. Supiot et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now